The enzyme amylase originates in either the pancreas or salivary glands and aids the body’s digestive process. Pancreatic amylase is secreted through the pancreatic duct into the duodenum and its primary function is to break down fats, proteins and carbohydrates as a first step in the digestion process. Amylase produced by the salivary glands helps convert starches into complex sugars such as dextrose. Other tissues may also exhibit some amylase activity, including the ovaries, fallopian tubes, small and large intestine, liver, placenta and skeletal muscle. Amylase enzyme levels increase when these glands are inflamed or obstructed.
Amylase is usually present in the blood and urine in small quantities. Levels have been shown to increase in blood and urine after pancreatic cell injury (pancreatitis), in pancreatic duct obstructions (gallstones, or rarely with obstruction by pancreatic tumor) and in some genetic disorders that affect pancreatic function such as cystic fibrosis.
The primary use of total serum amylase is in the diagnosis of acute pancreatitis. In this disorder, serum amylase begins to rise within 2 to 12 hours of onset of symptoms, with peak levels occurring in 12 to 72 hours, and levels returning to normal usually within 4 days. Elevations of 4 to 6 times normal are usual, but some patients show lesser elevation and a few show no elevation. Serum amylase levels do not correlate with the severity of illness and a return to normal is not always an indicator of resolution of illness. In patients with hyperlipidemia the amylase levels may be normal; this can be approached by ultracentrifugation of the specimen or serial dilutions. Amylase is not specific to the pancreas or pancreatitis. Elevated levels can be seen in diseases such as ectopic pregnancy, intestinal diseases, salivary gland disease and mumps.
Note: The magnitude of the elevation of serum amylase activity is not related to the severity of pancreatic involvement; however, the greater the rise, the greater the probability of acute pancreatitis.
Serum Ranges:
Adult 20–104 U/L (0.34–1.77 ukat/L)
Urine Ranges:
Adult <= 650 U/L (<= 10.9 ukat/L)
Enzymatic/chemiluminescent
Lipase, Amylase Isoenzymes, Bilirubin Direct and Total, Comprehensive Metabolic Panel, Bile Fluid Examination, Calcium Serum, C-reactive protein, Urine amylase.
Usually 1 day after receipt in performing laboratory.
| 82150 | $6.48$6.48 |
| ICD10 Code - Description | LCD Code | NCD Code |
|---|---|---|
| A41 - Other sepsis | ||
| A41.02 - Sepsis due to Methicillin resistant Staphylococcus aureus | ||
| A49.02 - Methicillin resistant Staphylococcus aureus infection, unspecified site | ||
| B26 - Mumps | ||
| B26.89 - Other mumps complications | ||
| B26.9 - Mumps without complication | ||
| B95.62 - Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere | ||
| C07 - Malignant neoplasm of parotid gland | ||
| C08 - Malignant neoplasm of other and unspecified major salivary glands | ||
| C08.0 - Malignant neoplasm of submandibular gland | ||
| C08.1 - Malignant neoplasm of sublingual gland | ||
| C08.9 - Malignant neoplasm of major salivary gland, unspecified | ||
| C16 - Malignant neoplasm of stomach | ||
| C16.0 - Malignant neoplasm of cardia | ||
| C16.1 - Malignant neoplasm of fundus of stomach | ||
| C16.2 - Malignant neoplasm of body of stomach | ||
| C16.3 - Malignant neoplasm of pyloric antrum | ||
| C16.4 - Malignant neoplasm of pylorus | ||
| C16.5 - Malignant neoplasm of lesser curvature of stomach, unspecified | ||
| C16.6 - Malignant neoplasm of greater curvature of stomach, unspecified | ||
| C16.8 - Malignant neoplasm of overlapping sites of stomach | ||
| C16.9 - Malignant neoplasm of stomach, unspecified | ||
| C17 - Malignant neoplasm of small intestine | ||
| C17.9 - Malignant neoplasm of small intestine, unspecified | ||
| C22 - Malignant neoplasm of liver and intrahepatic bile ducts | ||
| C22.0 - Liver cell carcinoma | ||
| C22.1 - Intrahepatic bile duct carcinoma | ||
| C22.8 - Malignant neoplasm of liver, primary, unspecified as to type | ||
| C22.9 - Malignant neoplasm of liver, not specified as primary or secondary | ||
| C23 - Malignant neoplasm of gallbladder | ||
| C24 - Malignant neoplasm of other and unspecified parts of biliary tract | ||
| C24.0 - Malignant neoplasm of extrahepatic bile duct | ||
| C25 - Malignant neoplasm of pancreas | ||
| C25.0 - Malignant neoplasm of head of pancreas | ||
| C25.1 - Malignant neoplasm of body of pancreas | ||
| C25.2 - Malignant neoplasm of tail of pancreas | ||
| C25.3 - Malignant neoplasm of pancreatic duct | ||
| C25.4 - Malignant neoplasm of endocrine pancreas | ||
| C25.7 - Malignant neoplasm of other parts of pancreas | ||
| C25.9 - Malignant neoplasm of pancreas, unspecified | ||
| C26 - Malignant neoplasm of other and ill-defined digestive organs | ||
| C26.9 - Malignant neoplasm of ill-defined sites within the digestive system | ||
| D00 - Carcinoma in situ of oral cavity, esophagus and stomach | ||
| D01.5 - Carcinoma in situ of liver, gallbladder and bile ducts | ||
| D11 - Benign neoplasm of major salivary glands | ||
| D13 - Benign neoplasm of other and ill-defined parts of digestive system | ||
| D13.4 - Benign neoplasm of liver | ||
| D13.5 - Benign neoplasm of extrahepatic bile ducts | ||
| D13.6 - Benign neoplasm of pancreas | ||
| D37.1 - Neoplasm of uncertain behavior of stomach | ||
| D37.6 - Neoplasm of uncertain behavior of liver, gallbladder and bile ducts | ||
| D37.9 - Neoplasm of uncertain behavior of digestive organ, unspecified | ||
| D61 - Other aplastic anemias and other bone marrow failure syndromes | ||
| D61.0 - Constitutional aplastic anemia | ||
| D61.3 - Idiopathic aplastic anemia | ||
| D61.89 - Other specified aplastic anemias and other bone marrow failure syndromes | ||
| D61.9 - Aplastic anemia, unspecified | ||
| D69 - Purpura and other hemorrhagic conditions | ||
| D69.0 - Allergic purpura | ||
| D69.2 - Other nonthrombocytopenic purpura | ||
| D70 - Neutropenia | ||
| D70.9 - Neutropenia, unspecified | ||
| E44 - Protein-calorie malnutrition of moderate and mild degree | ||
| E44.0 - Moderate protein-calorie malnutrition | ||
| E44.1 - Mild protein-calorie malnutrition | ||
| E78 - Disorders of lipoprotein metabolism and other lipidemias | ||
| E78.1 - Pure hyperglyceridemia | ||
| E78.2 - Mixed hyperlipidemia | ||
| E78.6 - Lipoprotein deficiency | ||
| E78.9 - Disorder of lipoprotein metabolism, unspecified | ||
| E84 - Cystic fibrosis | ||
| E84.0 - Cystic fibrosis with pulmonary manifestations | ||
| E84.1 - Cystic fibrosis with intestinal manifestations | ||
| E84.11 - Meconium ileus in cystic fibrosis | ||
| E84.19 - Cystic fibrosis with other intestinal manifestations | ||
| E84.8 - Cystic fibrosis with other manifestations | ||
| E84.9 - Cystic fibrosis, unspecified | ||
| F10 - Alcohol related disorders | ||
| F10.1 - Alcohol abuse | ||
| F10.10 - Alcohol abuse, uncomplicated | ||
| F10.12 - Alcohol abuse with intoxication | ||
| F10.120 - Alcohol abuse with intoxication, uncomplicated | ||
| F10.150 - Alcohol abuse with alcohol-induced psychotic disorder with delusions | ||
| F10.2 - Alcohol dependence | ||
| F10.20 - Alcohol dependence, uncomplicated | ||
| F10.21 - Alcohol dependence, in remission | ||
| F10.9 - Alcohol use, unspecified | ||
| F55 - Abuse of non-psychoactive substances | ||
| G89.29 - Other chronic pain | ||
| G93 - Other disorders of brain | ||
| G93.4 - Other and unspecified encephalopathy | ||
| G93.40 - Encephalopathy, unspecified | ||
| G93.41 - Metabolic encephalopathy | ||
| G93.7 - Reye's syndrome | ||
| J15.212 - Pneumonia due to Methicillin resistant Staphylococcus aureus | ||
| K11 - Diseases of salivary glands | ||
| K11.2 - Sialoadenitis | ||
| K11.20 - Sialoadenitis, unspecified | ||
| K11.21 - Acute sialoadenitis | ||
| K11.22 - Acute recurrent sialoadenitis | ||
| K11.23 - Chronic sialoadenitis | ||
| K11.3 - Abscess of salivary gland | ||
| K25 - Gastric ulcer | ||
| K25.0 - Acute gastric ulcer with hemorrhage | ||
| K25.1 - Acute gastric ulcer with perforation | ||
| K25.2 - Acute gastric ulcer with both hemorrhage and perforation | ||
| K25.3 - Acute gastric ulcer without hemorrhage or perforation | ||
| K25.4 - Chronic or unspecified gastric ulcer with hemorrhage | ||
| K25.6 - Chronic or unspecified gastric ulcer with both hemorrhage and perforation | ||
| K25.7 - Chronic gastric ulcer without hemorrhage or perforation | ||
| K26 - Duodenal ulcer | ||
| K27 - Peptic ulcer, site unspecified | ||
| K27.7 - Chronic peptic ulcer, site unspecified, without hemorrhage or perforation | ||
| K29 - Gastritis and duodenitis | ||
| K35 - Acute appendicitis | ||
| K35.2 - Acute appendicitis with generalized peritonitis | ||
| K35.3 - Acute appendicitis with localized peritonitis | ||
| K35.80 - Unspecified acute appendicitis | ||
| K35.89 - Other acute appendicitis | ||
| K52 - Other and unspecified noninfective gastroenteritis and colitis | ||
| K57 - Diverticular disease of intestine | ||
| K57.20 - Diverticulitis of large intestine with perforation and abscess without bleeding | ||
| K57.32 - Diverticulitis of large intestine without perforation or abscess without bleeding | ||
| K57.40 - Diverticulitis of both small and large intestine with perforation and abscess without bleeding | ||
| K57.52 - Diverticulitis of both small and large intestine without perforation or abscess without bleeding | ||
| K57.80 - Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding | ||
| K57.92 - Diverticulitis of intestine, part unspecified, without perforation or abscess without bleeding | ||
| K65 - Peritonitis | ||
| K65.1 - Peritoneal abscess | ||
| K65.8 - Other peritonitis | ||
| K65.9 - Peritonitis, unspecified | ||
| K67 - Disorders of peritoneum in infectious diseases classified elsewhere | ||
| K70 - Alcoholic liver disease | ||
| K70.0 - Alcoholic fatty liver | ||
| K70.1 - Alcoholic hepatitis | ||
| K70.10 - Alcoholic hepatitis without ascites | ||
| K70.11 - Alcoholic hepatitis with ascites | ||
| K70.9 - Alcoholic liver disease, unspecified | ||
| K71 - Toxic liver disease | ||
| K71.3 - Toxic liver disease with chronic persistent hepatitis | ||
| K71.9 - Toxic liver disease, unspecified | ||
| K72 - Hepatic failure, not elsewhere classified | ||
| K72.0 - Acute and subacute hepatic failure | ||
| K72.00 - Acute and subacute hepatic failure without coma | ||
| K72.01 - Acute and subacute hepatic failure with coma | ||
| K72.11 - Chronic hepatic failure with coma | ||
| K72.90 - Hepatic failure, unspecified without coma | ||
| K72.91 - Hepatic failure, unspecified with coma | ||
| K74 - Fibrosis and cirrhosis of liver | ||
| K74.69 - Other cirrhosis of liver | ||
| K75 - Other inflammatory liver diseases | ||
| K75.0 - Abscess of liver | ||
| K76 - Other diseases of liver | ||
| K76.0 - Fatty (change of) liver, not elsewhere classified | ||
| K76.1 - Chronic passive congestion of liver | ||
| K76.2 - Central hemorrhagic necrosis of liver | ||
| K76.3 - Infarction of liver | ||
| K76.8 - Other specified diseases of liver | ||
| K76.89 - Other specified diseases of liver | ||
| K76.9 - Liver disease, unspecified | ||
| K77 - Liver disorders in diseases classified elsewhere | ||
| K80 - Cholelithiasis | ||
| K80.0 - Calculus of gallbladder with acute cholecystitis | ||
| K80.1 - Calculus of gallbladder with other cholecystitis | ||
| K81 - Cholecystitis | ||
| K81.0 - Acute cholecystitis | ||
| K81.1 - Chronic cholecystitis | ||
| K81.2 - Acute cholecystitis with chronic cholecystitis | ||
| K81.9 - Cholecystitis, unspecified | ||
| K83 - Other diseases of biliary tract | ||
| K83.0 - Cholangitis | ||
| K83.1 - Obstruction of bile duct | ||
| K83.9 - Disease of biliary tract, unspecified | ||
| K85 - Acute pancreatitis | ||
| K85.0 - Idiopathic acute pancreatitis | ||
| K85.1 - Biliary acute pancreatitis | ||
| K85.2 - Alcohol induced acute pancreatitis | ||
| K85.20 - Alcohol induced acute pancreatitis without necrosis or infection | ||
| K85.3 - Drug induced acute pancreatitis | ||
| K85.8 - Other acute pancreatitis | ||
| K85.9 - Acute pancreatitis, unspecified | ||
| K86 - Other diseases of pancreas | ||
| K86.0 - Alcohol-induced chronic pancreatitis | ||
| K86.1 - Other chronic pancreatitis | ||
| K86.2 - Cyst of pancreas | ||
| K86.3 - Pseudocyst of pancreas | ||
| K86.8 - Other specified diseases of pancreas | ||
| K86.81 - Exocrine pancreatic insufficiency | ||
| K86.9 - Disease of pancreas, unspecified | ||
| K90 - Intestinal malabsorption | ||
| K90.89 - Other intestinal malabsorption | ||
| K90.9 - Intestinal malabsorption, unspecified | ||
| M25.48 - Effusion, other site | ||
| M36 - Systemic disorders of connective tissue in diseases classified elsewhere | ||
| M36.4 - Arthropathy in hypersensitivity reactions classified elsewhere | ||
| P36.30 - Sepsis of newborn due to unspecified staphylococci | ||
| P58 - Neonatal jaundice due to other excessive hemolysis | ||
| P59 - Neonatal jaundice from other and unspecified causes | ||
| P59.0 - Neonatal jaundice associated with preterm delivery | ||
| P59.9 - Neonatal jaundice, unspecified | ||
| Q82 - Other congenital malformations of skin | ||
| R10 - Abdominal and pelvic pain | ||
| R10.0 - Acute abdomen | ||
| R10.10 - Upper abdominal pain, unspecified | ||
| R10.30 - Lower abdominal pain, unspecified | ||
| R10.8 - Other abdominal pain | ||
| R10.84 - Generalized abdominal pain | ||
| R10.9 - Unspecified abdominal pain | ||
| R17 - Unspecified jaundice | ||
| R18 - Ascites | ||
| R18.8 - Other ascites | ||
| R19 - Other symptoms and signs involving the digestive system and abdomen | ||
| R50 - Fever of other and unknown origin | ||
| R50.9 - Fever, unspecified | ||
| R65 - Symptoms and signs specifically associated with systemic inflammation and infection | ||
| R65.1 - Systemic inflammatory response syndrome (SIRS) of non-infectious origin | ||
| R65.11 - Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunction | ||
| R65.2 - Severe sepsis | ||
| R65.20 - Severe sepsis without septic shock | ||
| R65.21 - Severe sepsis with septic shock | ||
| R74 - Abnormal serum enzyme levels | ||
| R74.0 - Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH] | ||
| R74.01 - Elevation of levels of liver transaminase levels | ||
| R78.0 - Finding of alcohol in blood | ||
| R85 - Abnormal findings in specimens from digestive organs and abdominal cavity | ||
| R85.9 - Unspecified abnormal finding in specimens from digestive organs and abdominal cavity | ||
| R94 - Abnormal results of function studies | ||
| R94.5 - Abnormal results of liver function studies | ||
| T39 - Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics | ||
| T39.013 - Poisoning by aspirin, assault | ||
| T39.094S - Poisoning by salicylates, undetermined, sequela | ||
| T39.1 - Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives | ||
| T39.1X1 - Poisoning by 4-Aminophenol derivatives, accidental (unintentional) | ||
| T39.1X2 - Poisoning by 4-Aminophenol derivatives, intentional self-harm | ||
| T39.1X3 - Poisoning by 4-Aminophenol derivatives, assault | ||
| T39.1X4 - Poisoning by 4-Aminophenol derivatives, undetermined | ||
| Z02.83 - Encounter for blood-alcohol and blood-drug test | ||
| Z13.71 - Encounter for nonprocreative screening for genetic disease carrier status | ||
| Z14.1 - Cystic fibrosis carrier | ||
| Z22.322 - Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus | ||
| Z31.430 - Encounter of female for testing for genetic disease carrier status for procreative management | ||
| Z31.440 - Encounter of male for testing for genetic disease carrier status for procreative management | ||
| Z51.0 - Encounter for antineoplastic radiation therapy | ||
| Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy | ||
| Z51.11 - Encounter for antineoplastic chemotherapy | ||
| Z51.12 - Encounter for antineoplastic immunotherapy | ||
| Z71.4 - Alcohol abuse counseling and surveillance | ||
| Z79 - Long term (current) drug therapy | ||
| Z79.89 - Other long term (current) drug therapy | ||
| Z79.899 - Other long term (current) drug therapy | ||
| Z81.1 - Family history of alcohol abuse and dependence | ||
| Z84.81 - Family history of carrier of genetic disease | ||
| Z85 - Personal history of malignant neoplasm | ||
| Z85.0 - Personal history of malignant neoplasm of digestive organs | ||
| Z85.00 - Personal history of malignant neoplasm of unspecified digestive organ | ||
| Z85.020 - Personal history of malignant carcinoid tumor of stomach | ||
| Z85.028 - Personal history of other malignant neoplasm of stomach | ||
| Z85.05 - Personal history of malignant neoplasm of liver | ||
| Z85.07 - Personal history of malignant neoplasm of pancreas | ||
| Z85.09 - Personal history of malignant neoplasm of other digestive organs | ||
| Z86.14 - Personal history of Methicillin resistant Staphylococcus aureus infection | ||
| ICD10 Code - Description | LCD Code | NCD Code |
|---|---|---|
| A06.4 - Amebic liver abscess | ||
| A41.0 - Sepsis due to Staphylococcus aureus | ||
| A41.01 - Sepsis due to Methicillin susceptible Staphylococcus aureus | ||
| A41.02 - Sepsis due to Methicillin resistant Staphylococcus aureus | ||
| A41.1 - Sepsis due to other specified staphylococcus | ||
| A41.2 - Sepsis due to unspecified staphylococcus | ||
| A41.3 - Sepsis due to Hemophilus influenzae | ||
| A41.4 - Sepsis due to anaerobes | ||
| A41.5 - Sepsis due to other Gram-negative organisms | ||
| A41.50 - Gram-negative sepsis, unspecified | ||
| A41.51 - Sepsis due to Escherichia coli [E. coli] | ||
| A41.52 - Sepsis due to Pseudomonas | ||
| A41.53 - Sepsis due to Serratia | ||
| A41.59 - Other Gram-negative sepsis | ||
| A41.8 - Other specified sepsis | ||
| A41.81 - Sepsis due to Enterococcus | ||
| A41.89 - Other specified sepsis | ||
| A41.9 - Sepsis, unspecified organism | ||
| A49.02 - Methicillin resistant Staphylococcus aureus infection, unspecified site | ||
| B18.0 - Chronic viral hepatitis B with delta-agent | ||
| B18.1 - Chronic viral hepatitis B without delta-agent | ||
| B18.2 - Chronic viral hepatitis C | ||
| B19.0 - Unspecified viral hepatitis with hepatic coma | ||
| B19.1 - Unspecified viral hepatitis B | ||
| B19.10 - Unspecified viral hepatitis B without hepatic coma | ||
| B19.11 - Unspecified viral hepatitis B with hepatic coma | ||
| B19.2 - Unspecified viral hepatitis C | ||
| B19.20 - Unspecified viral hepatitis C without hepatic coma | ||
| B19.21 - Unspecified viral hepatitis C with hepatic coma | ||
| B19.9 - Unspecified viral hepatitis without hepatic coma | ||
| B25.2 - Cytomegaloviral pancreatitis | ||
| B26.0 - Mumps orchitis | ||
| B26.1 - Mumps meningitis | ||
| B26.2 - Mumps encephalitis | ||
| B26.3 - Mumps pancreatitis | ||
| B26.8 - Mumps with other complications | ||
| B26.81 - Mumps hepatitis | ||
| B26.82 - Mumps myocarditis | ||
| B26.83 - Mumps nephritis | ||
| B26.84 - Mumps polyneuropathy | ||
| B26.85 - Mumps arthritis | ||
| B26.89 - Other mumps complications | ||
| B26.9 - Mumps without complication | ||
| B95.62 - Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere | ||
| C08.0 - Malignant neoplasm of submandibular gland | ||
| C08.1 - Malignant neoplasm of sublingual gland | ||
| C08.9 - Malignant neoplasm of major salivary gland, unspecified | ||
| C16.0 - Malignant neoplasm of cardia | ||
| C16.1 - Malignant neoplasm of fundus of stomach | ||
| C16.2 - Malignant neoplasm of body of stomach | ||
| C16.3 - Malignant neoplasm of pyloric antrum | ||
| C16.4 - Malignant neoplasm of pylorus | ||
| C16.5 - Malignant neoplasm of lesser curvature of stomach, unspecified | ||
| C16.6 - Malignant neoplasm of greater curvature of stomach, unspecified | ||
| C16.8 - Malignant neoplasm of overlapping sites of stomach | ||
| C16.9 - Malignant neoplasm of stomach, unspecified | ||
| C17.0 - Malignant neoplasm of duodenum | ||
| C17.1 - Malignant neoplasm of jejunum | ||
| C17.2 - Malignant neoplasm of ileum | ||
| C17.3 - Meckel's diverticulum, malignant | ||
| C17.8 - Malignant neoplasm of overlapping sites of small intestine | ||
| C17.9 - Malignant neoplasm of small intestine, unspecified | ||
| C22.0 - Liver cell carcinoma | ||
| C22.1 - Intrahepatic bile duct carcinoma | ||
| C22.2 - Hepatoblastoma | ||
| C22.3 - Angiosarcoma of liver | ||
| C22.4 - Other sarcomas of liver | ||
| C22.7 - Other specified carcinomas of liver | ||
| C22.8 - Malignant neoplasm of liver, primary, unspecified as to type | ||
| C22.9 - Malignant neoplasm of liver, not specified as primary or secondary | ||
| C24.0 - Malignant neoplasm of extrahepatic bile duct | ||
| C24.1 - Malignant neoplasm of ampulla of Vater | ||
| C24.8 - Malignant neoplasm of overlapping sites of biliary tract | ||
| C24.9 - Malignant neoplasm of biliary tract, unspecified | ||
| C25.0 - Malignant neoplasm of head of pancreas | ||
| C25.1 - Malignant neoplasm of body of pancreas | ||
| C25.2 - Malignant neoplasm of tail of pancreas | ||
| C25.3 - Malignant neoplasm of pancreatic duct | ||
| C25.4 - Malignant neoplasm of endocrine pancreas | ||
| C25.7 - Malignant neoplasm of other parts of pancreas | ||
| C25.8 - Malignant neoplasm of overlapping sites of pancreas | ||
| C25.9 - Malignant neoplasm of pancreas, unspecified | ||
| C26.0 - Malignant neoplasm of intestinal tract, part unspecified | ||
| C26.1 - Malignant neoplasm of spleen | ||
| C26.9 - Malignant neoplasm of ill-defined sites within the digestive system | ||
| C49.A2 - Gastrointestinal stromal tumor of stomach | ||
| C78.7 - Secondary malignant neoplasm of liver and intrahepatic bile duct | ||
| C7A.092 - Malignant carcinoid tumor of the stomach | ||
| C7B.02 - Secondary carcinoid tumors of liver | ||
| D00.0 - Carcinoma in situ of lip, oral cavity and pharynx | ||
| D00.00 - Carcinoma in situ of oral cavity, unspecified site | ||
| D00.01 - Carcinoma in situ of labial mucosa and vermilion border | ||
| D00.02 - Carcinoma in situ of buccal mucosa | ||
| D00.03 - Carcinoma in situ of gingiva and edentulous alveolar ridge | ||
| D00.04 - Carcinoma in situ of soft palate | ||
| D00.05 - Carcinoma in situ of hard palate | ||
| D00.06 - Carcinoma in situ of floor of mouth | ||
| D00.07 - Carcinoma in situ of tongue | ||
| D00.08 - Carcinoma in situ of pharynx | ||
| D00.1 - Carcinoma in situ of esophagus | ||
| D00.2 - Carcinoma in situ of stomach | ||
| D01.5 - Carcinoma in situ of liver, gallbladder and bile ducts | ||
| D01.9 - Carcinoma in situ of digestive organ, unspecified | ||
| D11.0 - Benign neoplasm of parotid gland | ||
| D11.7 - Benign neoplasm of other major salivary glands | ||
| D11.9 - Benign neoplasm of major salivary gland, unspecified | ||
| D13.0 - Benign neoplasm of esophagus | ||
| D13.1 - Benign neoplasm of stomach | ||
| D13.2 - Benign neoplasm of duodenum | ||
| D13.3 - Benign neoplasm of other and unspecified parts of small intestine | ||
| D13.30 - Benign neoplasm of unspecified part of small intestine | ||
| D13.39 - Benign neoplasm of other parts of small intestine | ||
| D13.4 - Benign neoplasm of liver | ||
| D13.5 - Benign neoplasm of extrahepatic bile ducts | ||
| D13.6 - Benign neoplasm of pancreas | ||
| D13.7 - Benign neoplasm of endocrine pancreas | ||
| D13.9 - Benign neoplasm of ill-defined sites within the digestive system | ||
| D37.03 - Neoplasm of uncertain behavior of the major salivary glands | ||
| D37.030 - Neoplasm of uncertain behavior of the parotid salivary glands | ||
| D37.031 - Neoplasm of uncertain behavior of the sublingual salivary glands | ||
| D37.032 - Neoplasm of uncertain behavior of the submandibular salivary glands | ||
| D37.039 - Neoplasm of uncertain behavior of the major salivary glands, unspecified | ||
| D37.04 - Neoplasm of uncertain behavior of the minor salivary glands | ||
| D37.1 - Neoplasm of uncertain behavior of stomach | ||
| D37.4 - Neoplasm of uncertain behavior of colon | ||
| D37.5 - Neoplasm of uncertain behavior of rectum | ||
| D37.6 - Neoplasm of uncertain behavior of liver, gallbladder and bile ducts | ||
| D37.8 - Neoplasm of uncertain behavior of other specified digestive organs | ||
| D37.9 - Neoplasm of uncertain behavior of digestive organ, unspecified | ||
| D3A.092 - Benign carcinoid tumor of the stomach | ||
| D61.0 - Constitutional aplastic anemia | ||
| D61.01 - Constitutional (pure) red blood cell aplasia | ||
| D61.09 - Other constitutional aplastic anemia | ||
| D61.1 - Drug-induced aplastic anemia | ||
| D61.2 - Aplastic anemia due to other external agents | ||
| D61.3 - Idiopathic aplastic anemia | ||
| D61.8 - Other specified aplastic anemias and other bone marrow failure syndromes | ||
| D61.81 - Pancytopenia | ||
| D61.810 - Antineoplastic chemotherapy induced pancytopenia | ||
| D61.811 - Other drug-induced pancytopenia | ||
| D61.818 - Other pancytopenia | ||
| D61.82 - Myelophthisis | ||
| D61.89 - Other specified aplastic anemias and other bone marrow failure syndromes | ||
| D61.9 - Aplastic anemia, unspecified | ||
| D64.81 - Anemia due to antineoplastic chemotherapy | ||
| D69.0 - Allergic purpura | ||
| D69.1 - Qualitative platelet defects | ||
| D69.2 - Other nonthrombocytopenic purpura | ||
| D69.3 - Immune thrombocytopenic purpura | ||
| D69.4 - Other primary thrombocytopenia | ||
| D69.41 - Evans syndrome | ||
| D69.42 - Congenital and hereditary thrombocytopenia purpura | ||
| D69.49 - Other primary thrombocytopenia | ||
| D69.5 - Secondary thrombocytopenia | ||
| D69.51 - Posttransfusion purpura | ||
| D69.59 - Other secondary thrombocytopenia | ||
| D69.6 - Thrombocytopenia, unspecified | ||
| D69.8 - Other specified hemorrhagic conditions | ||
| D69.9 - Hemorrhagic condition, unspecified | ||
| D70.0 - Congenital agranulocytosis | ||
| D70.1 - Agranulocytosis secondary to cancer chemotherapy | ||
| D70.2 - Other drug-induced agranulocytosis | ||
| D70.3 - Neutropenia due to infection | ||
| D70.4 - Cyclic neutropenia | ||
| D70.8 - Other neutropenia | ||
| D70.9 - Neutropenia, unspecified | ||
| E44.0 - Moderate protein-calorie malnutrition | ||
| E44.1 - Mild protein-calorie malnutrition | ||
| E78.0 - Pure hypercholesterolemia | ||
| E78.00 - Pure hypercholesterolemia, unspecified | ||
| E78.01 - Familial hypercholesterolemia | ||
| E78.1 - Pure hyperglyceridemia | ||
| E78.2 - Mixed hyperlipidemia | ||
| E78.3 - Hyperchylomicronemia | ||
| E78.4 - Other hyperlipidemia | ||
| E78.41 - Elevated Lipoprotein(a) | ||
| E78.49 - Other hyperlipidemia | ||
| E78.5 - Hyperlipidemia, unspecified | ||
| E78.6 - Lipoprotein deficiency | ||
| E78.7 - Disorders of bile acid and cholesterol metabolism | ||
| E78.70 - Disorder of bile acid and cholesterol metabolism, unspecified | ||
| E78.71 - Barth syndrome | ||
| E78.72 - Smith-Lemli-Opitz syndrome | ||
| E78.79 - Other disorders of bile acid and cholesterol metabolism | ||
| E78.8 - Other disorders of lipoprotein metabolism | ||
| E78.81 - Lipoid dermatoarthritis | ||
| E78.89 - Other lipoprotein metabolism disorders | ||
| E78.9 - Disorder of lipoprotein metabolism, unspecified | ||
| E84.0 - Cystic fibrosis with pulmonary manifestations | ||
| E84.1 - Cystic fibrosis with intestinal manifestations | ||
| E84.11 - Meconium ileus in cystic fibrosis | ||
| E84.19 - Cystic fibrosis with other intestinal manifestations | ||
| E84.8 - Cystic fibrosis with other manifestations | ||
| E84.9 - Cystic fibrosis, unspecified | ||
| F10.1 - Alcohol abuse | ||
| F10.10 - Alcohol abuse, uncomplicated | ||
| F10.11 - Alcohol abuse, in remission | ||
| F10.12 - Alcohol abuse with intoxication | ||
| F10.120 - Alcohol abuse with intoxication, uncomplicated | ||
| F10.121 - Alcohol abuse with intoxication delirium | ||
| F10.129 - Alcohol abuse with intoxication, unspecified | ||
| F10.13 - Alcohol abuse, with withdrawal | ||
| F10.130 - Alcohol abuse with withdrawal, uncomplicated | ||
| F10.131 - Alcohol abuse with withdrawal delirium | ||
| F10.132 - Alcohol abuse with withdrawal with perceptual disturbance | ||
| F10.139 - Alcohol abuse with withdrawal, unspecified | ||
| F10.14 - Alcohol abuse with alcohol-induced mood disorder | ||
| F10.15 - Alcohol abuse with alcohol-induced psychotic disorder | ||
| F10.150 - Alcohol abuse with alcohol-induced psychotic disorder with delusions | ||
| F10.151 - Alcohol abuse with alcohol-induced psychotic disorder with hallucinations | ||
| F10.159 - Alcohol abuse with alcohol-induced psychotic disorder, unspecified | ||
| F10.18 - Alcohol abuse with other alcohol-induced disorders | ||
| F10.180 - Alcohol abuse with alcohol-induced anxiety disorder | ||
| F10.181 - Alcohol abuse with alcohol-induced sexual dysfunction | ||
| F10.182 - Alcohol abuse with alcohol-induced sleep disorder | ||
| F10.188 - Alcohol abuse with other alcohol-induced disorder | ||
| F10.19 - Alcohol abuse with unspecified alcohol-induced disorder | ||
| F10.2 - Alcohol dependence | ||
| F10.20 - Alcohol dependence, uncomplicated | ||
| F10.21 - Alcohol dependence, in remission | ||
| F10.22 - Alcohol dependence with intoxication | ||
| F10.220 - Alcohol dependence with intoxication, uncomplicated | ||
| F10.221 - Alcohol dependence with intoxication delirium | ||
| F10.229 - Alcohol dependence with intoxication, unspecified | ||
| F10.23 - Alcohol dependence with withdrawal | ||
| F10.230 - Alcohol dependence with withdrawal, uncomplicated | ||
| F10.231 - Alcohol dependence with withdrawal delirium | ||
| F10.232 - Alcohol dependence with withdrawal with perceptual disturbance | ||
| F10.239 - Alcohol dependence with withdrawal, unspecified | ||
| F10.24 - Alcohol dependence with alcohol-induced mood disorder | ||
| F10.25 - Alcohol dependence with alcohol-induced psychotic disorder | ||
| F10.250 - Alcohol dependence with alcohol-induced psychotic disorder with delusions | ||
| F10.251 - Alcohol dependence with alcohol-induced psychotic disorder with hallucinations | ||
| F10.259 - Alcohol dependence with alcohol-induced psychotic disorder, unspecified | ||
| F10.26 - Alcohol dependence with alcohol-induced persisting amnestic disorder | ||
| F10.27 - Alcohol dependence with alcohol-induced persisting dementia | ||
| F10.28 - Alcohol dependence with other alcohol-induced disorders | ||
| F10.280 - Alcohol dependence with alcohol-induced anxiety disorder | ||
| F10.281 - Alcohol dependence with alcohol-induced sexual dysfunction | ||
| F10.282 - Alcohol dependence with alcohol-induced sleep disorder | ||
| F10.288 - Alcohol dependence with other alcohol-induced disorder | ||
| F10.29 - Alcohol dependence with unspecified alcohol-induced disorder | ||
| F10.9 - Alcohol use, unspecified | ||
| F10.92 - Alcohol use, unspecified with intoxication | ||
| F10.920 - Alcohol use, unspecified with intoxication, uncomplicated | ||
| F10.921 - Alcohol use, unspecified with intoxication delirium | ||
| F10.929 - Alcohol use, unspecified with intoxication, unspecified | ||
| F10.93 - Alcohol use, unspecified with withdrawal | ||
| F10.930 - Alcohol use, unspecified with withdrawal, uncomplicated | ||
| F10.931 - Alcohol use, unspecified with withdrawal delirium | ||
| F10.932 - Alcohol use, unspecified with withdrawal with perceptual disturbance | ||
| F10.939 - Alcohol use, unspecified with withdrawal, unspecified | ||
| F10.94 - Alcohol use, unspecified with alcohol-induced mood disorder | ||
| F10.95 - Alcohol use, unspecified with alcohol-induced psychotic disorder | ||
| F10.950 - Alcohol use, unspecified with alcohol-induced psychotic disorder with delusions | ||
| F10.951 - Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations | ||
| F10.959 - Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified | ||
| F10.96 - Alcohol use, unspecified with alcohol-induced persisting amnestic disorder | ||
| F10.97 - Alcohol use, unspecified with alcohol-induced persisting dementia | ||
| F10.98 - Alcohol use, unspecified with other alcohol-induced disorders | ||
| F10.980 - Alcohol use, unspecified with alcohol-induced anxiety disorder | ||
| F10.981 - Alcohol use, unspecified with alcohol-induced sexual dysfunction | ||
| F10.982 - Alcohol use, unspecified with alcohol-induced sleep disorder | ||
| F10.988 - Alcohol use, unspecified with other alcohol-induced disorder | ||
| F10.99 - Alcohol use, unspecified with unspecified alcohol-induced disorder | ||
| F55.0 - Abuse of antacids | ||
| F55.1 - Abuse of herbal or folk remedies | ||
| F55.2 - Abuse of laxatives | ||
| F55.3 - Abuse of steroids or hormones | ||
| F55.4 - Abuse of vitamins | ||
| F55.8 - Abuse of other non-psychoactive substances | ||
| G93.2 - Benign intracranial hypertension | ||
| G93.3 - Postviral fatigue syndrome | ||
| G93.4 - Other and unspecified encephalopathy | ||
| G93.40 - Encephalopathy, unspecified | ||
| G93.41 - Metabolic encephalopathy | ||
| G93.49 - Other encephalopathy | ||
| G93.5 - Compression of brain | ||
| G93.6 - Cerebral edema | ||
| G93.7 - Reye's syndrome | ||
| G93.8 - Other specified disorders of brain | ||
| G93.81 - Temporal sclerosis | ||
| G93.82 - Brain death | ||
| G93.89 - Other specified disorders of brain | ||
| G93.9 - Disorder of brain, unspecified | ||
| J15.212 - Pneumonia due to Methicillin resistant Staphylococcus aureus | ||
| K11.0 - Atrophy of salivary gland | ||
| K11.1 - Hypertrophy of salivary gland | ||
| K11.2 - Sialoadenitis | ||
| K11.20 - Sialoadenitis, unspecified | ||
| K11.21 - Acute sialoadenitis | ||
| K11.22 - Acute recurrent sialoadenitis | ||
| K11.23 - Chronic sialoadenitis | ||
| K11.3 - Abscess of salivary gland | ||
| K11.4 - Fistula of salivary gland | ||
| K11.5 - Sialolithiasis | ||
| K11.6 - Mucocele of salivary gland | ||
| K11.7 - Disturbances of salivary secretion | ||
| K11.8 - Other diseases of salivary glands | ||
| K11.9 - Disease of salivary gland, unspecified | ||
| K25.0 - Acute gastric ulcer with hemorrhage | ||
| K25.1 - Acute gastric ulcer with perforation | ||
| K25.2 - Acute gastric ulcer with both hemorrhage and perforation | ||
| K25.3 - Acute gastric ulcer without hemorrhage or perforation | ||
| K25.4 - Chronic or unspecified gastric ulcer with hemorrhage | ||
| K25.5 - Chronic or unspecified gastric ulcer with perforation | ||
| K25.6 - Chronic or unspecified gastric ulcer with both hemorrhage and perforation | ||
| K25.7 - Chronic gastric ulcer without hemorrhage or perforation | ||
| K25.9 - Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation | ||
| K26.0 - Acute duodenal ulcer with hemorrhage | ||
| K26.1 - Acute duodenal ulcer with perforation | ||
| K26.2 - Acute duodenal ulcer with both hemorrhage and perforation | ||
| K26.3 - Acute duodenal ulcer without hemorrhage or perforation | ||
| K26.4 - Chronic or unspecified duodenal ulcer with hemorrhage | ||
| K26.5 - Chronic or unspecified duodenal ulcer with perforation | ||
| K26.6 - Chronic or unspecified duodenal ulcer with both hemorrhage and perforation | ||
| K26.7 - Chronic duodenal ulcer without hemorrhage or perforation | ||
| K26.9 - Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation | ||
| K27.0 - Acute peptic ulcer, site unspecified, with hemorrhage | ||
| K27.1 - Acute peptic ulcer, site unspecified, with perforation | ||
| K27.2 - Acute peptic ulcer, site unspecified, with both hemorrhage and perforation | ||
| K27.3 - Acute peptic ulcer, site unspecified, without hemorrhage or perforation | ||
| K27.4 - Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage | ||
| K27.5 - Chronic or unspecified peptic ulcer, site unspecified, with perforation | ||
| K27.6 - Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation | ||
| K27.7 - Chronic peptic ulcer, site unspecified, without hemorrhage or perforation | ||
| K27.9 - Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation | ||
| K29.0 - Acute gastritis | ||
| K29.00 - Acute gastritis without bleeding | ||
| K29.01 - Acute gastritis with bleeding | ||
| K29.2 - Alcoholic gastritis | ||
| K29.20 - Alcoholic gastritis without bleeding | ||
| K29.21 - Alcoholic gastritis with bleeding | ||
| K29.3 - Chronic superficial gastritis | ||
| K29.30 - Chronic superficial gastritis without bleeding | ||
| K29.31 - Chronic superficial gastritis with bleeding | ||
| K29.4 - Chronic atrophic gastritis | ||
| K29.40 - Chronic atrophic gastritis without bleeding | ||
| K29.41 - Chronic atrophic gastritis with bleeding | ||
| K29.5 - Unspecified chronic gastritis | ||
| K29.50 - Unspecified chronic gastritis without bleeding | ||
| K29.51 - Unspecified chronic gastritis with bleeding | ||
| K29.6 - Other gastritis | ||
| K29.60 - Other gastritis without bleeding | ||
| K29.61 - Other gastritis with bleeding | ||
| K29.7 - Gastritis, unspecified | ||
| K29.70 - Gastritis, unspecified, without bleeding | ||
| K29.71 - Gastritis, unspecified, with bleeding | ||
| K29.8 - Duodenitis | ||
| K29.80 - Duodenitis without bleeding | ||
| K29.81 - Duodenitis with bleeding | ||
| K29.9 - Gastroduodenitis, unspecified | ||
| K29.90 - Gastroduodenitis, unspecified, without bleeding | ||
| K29.91 - Gastroduodenitis, unspecified, with bleeding | ||
| K31.7 - Polyp of stomach and duodenum | ||
| K35.2 - Acute appendicitis with generalized peritonitis | ||
| K35.20 - Acute appendicitis with generalized peritonitis, without abscess | ||
| K35.200 - | ||
| K35.201 - | ||
| K35.209 - | ||
| K35.21 - Acute appendicitis with generalized peritonitis, with abscess | ||
| K35.210 - | ||
| K35.211 - | ||
| K35.219 - | ||
| K35.3 - Acute appendicitis with localized peritonitis | ||
| K35.30 - Acute appendicitis with localized peritonitis, without perforation or gangrene | ||
| K35.31 - Acute appendicitis with localized peritonitis and gangrene, without perforation | ||
| K35.32 - Acute appendicitis with perforation and localized peritonitis, without abscess | ||
| K35.33 - Acute appendicitis with perforation and localized peritonitis, with abscess | ||
| K35.8 - Other and unspecified acute appendicitis | ||
| K35.80 - Unspecified acute appendicitis | ||
| K35.89 - Other acute appendicitis | ||
| K35.890 - Other acute appendicitis without perforation or gangrene | ||
| K35.891 - Other acute appendicitis without perforation, with gangrene | ||
| K52.0 - Gastroenteritis and colitis due to radiation | ||
| K52.1 - Toxic gastroenteritis and colitis | ||
| K52.2 - Allergic and dietetic gastroenteritis and colitis | ||
| K52.21 - Food protein-induced enterocolitis syndrome | ||
| K52.22 - Food protein-induced enteropathy | ||
| K52.29 - Other allergic and dietetic gastroenteritis and colitis | ||
| K52.3 - Indeterminate colitis | ||
| K52.8 - Other specified noninfective gastroenteritis and colitis | ||
| K52.81 - Eosinophilic gastritis or gastroenteritis | ||
| K52.82 - Eosinophilic colitis | ||
| K52.83 - Microscopic colitis | ||
| K52.831 - Collagenous colitis | ||
| K52.832 - Lymphocytic colitis | ||
| K52.838 - Other microscopic colitis | ||
| K52.839 - Microscopic colitis, unspecified | ||
| K52.89 - Other specified noninfective gastroenteritis and colitis | ||
| K52.9 - Noninfective gastroenteritis and colitis, unspecified | ||
| K57.0 - Diverticulitis of small intestine with perforation and abscess | ||
| K57.00 - Diverticulitis of small intestine with perforation and abscess without bleeding | ||
| K57.01 - Diverticulitis of small intestine with perforation and abscess with bleeding | ||
| K57.1 - Diverticular disease of small intestine without perforation or abscess | ||
| K57.10 - Diverticulosis of small intestine without perforation or abscess without bleeding | ||
| K57.11 - Diverticulosis of small intestine without perforation or abscess with bleeding | ||
| K57.12 - Diverticulitis of small intestine without perforation or abscess without bleeding | ||
| K57.13 - Diverticulitis of small intestine without perforation or abscess with bleeding | ||
| K57.2 - Diverticulitis of large intestine with perforation and abscess | ||
| K57.20 - Diverticulitis of large intestine with perforation and abscess without bleeding | ||
| K57.21 - Diverticulitis of large intestine with perforation and abscess with bleeding | ||
| K57.3 - Diverticular disease of large intestine without perforation or abscess | ||
| K57.30 - Diverticulosis of large intestine without perforation or abscess without bleeding | ||
| K57.31 - Diverticulosis of large intestine without perforation or abscess with bleeding | ||
| K57.32 - Diverticulitis of large intestine without perforation or abscess without bleeding | ||
| K57.33 - Diverticulitis of large intestine without perforation or abscess with bleeding | ||
| K57.4 - Diverticulitis of both small and large intestine with perforation and abscess | ||
| K57.40 - Diverticulitis of both small and large intestine with perforation and abscess without bleeding | ||
| K57.41 - Diverticulitis of both small and large intestine with perforation and abscess with bleeding | ||
| K57.5 - Diverticular disease of both small and large intestine without perforation or abscess | ||
| K57.50 - Diverticulosis of both small and large intestine without perforation or abscess without bleeding | ||
| K57.51 - Diverticulosis of both small and large intestine without perforation or abscess with bleeding | ||
| K57.52 - Diverticulitis of both small and large intestine without perforation or abscess without bleeding | ||
| K57.53 - Diverticulitis of both small and large intestine without perforation or abscess with bleeding | ||
| K57.8 - Diverticulitis of intestine, part unspecified, with perforation and abscess | ||
| K57.80 - Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding | ||
| K57.81 - Diverticulitis of intestine, part unspecified, with perforation and abscess with bleeding | ||
| K57.9 - Diverticular disease of intestine, part unspecified, without perforation or abscess | ||
| K57.90 - Diverticulosis of intestine, part unspecified, without perforation or abscess without bleeding | ||
| K57.91 - Diverticulosis of intestine, part unspecified, without perforation or abscess with bleeding | ||
| K57.92 - Diverticulitis of intestine, part unspecified, without perforation or abscess without bleeding | ||
| K57.93 - Diverticulitis of intestine, part unspecified, without perforation or abscess with bleeding | ||
| K65.0 - Generalized (acute) peritonitis | ||
| K65.1 - Peritoneal abscess | ||
| K65.2 - Spontaneous bacterial peritonitis | ||
| K65.3 - Choleperitonitis | ||
| K65.4 - Sclerosing mesenteritis | ||
| K65.8 - Other peritonitis | ||
| K65.9 - Peritonitis, unspecified | ||
| K70.0 - Alcoholic fatty liver | ||
| K70.1 - Alcoholic hepatitis | ||
| K70.10 - Alcoholic hepatitis without ascites | ||
| K70.11 - Alcoholic hepatitis with ascites | ||
| K70.2 - Alcoholic fibrosis and sclerosis of liver | ||
| K70.3 - Alcoholic cirrhosis of liver | ||
| K70.30 - Alcoholic cirrhosis of liver without ascites | ||
| K70.31 - Alcoholic cirrhosis of liver with ascites | ||
| K70.4 - Alcoholic hepatic failure | ||
| K70.40 - Alcoholic hepatic failure without coma | ||
| K70.41 - Alcoholic hepatic failure with coma | ||
| K70.9 - Alcoholic liver disease, unspecified | ||
| K71.0 - Toxic liver disease with cholestasis | ||
| K71.1 - Toxic liver disease with hepatic necrosis | ||
| K71.10 - Toxic liver disease with hepatic necrosis, without coma | ||
| K71.11 - Toxic liver disease with hepatic necrosis, with coma | ||
| K71.2 - Toxic liver disease with acute hepatitis | ||
| K71.3 - Toxic liver disease with chronic persistent hepatitis | ||
| K71.4 - Toxic liver disease with chronic lobular hepatitis | ||
| K71.5 - Toxic liver disease with chronic active hepatitis | ||
| K71.50 - Toxic liver disease with chronic active hepatitis without ascites | ||
| K71.51 - Toxic liver disease with chronic active hepatitis with ascites | ||
| K71.6 - Toxic liver disease with hepatitis, not elsewhere classified | ||
| K71.7 - Toxic liver disease with fibrosis and cirrhosis of liver | ||
| K71.8 - Toxic liver disease with other disorders of liver | ||
| K71.9 - Toxic liver disease, unspecified | ||
| K72.0 - Acute and subacute hepatic failure | ||
| K72.00 - Acute and subacute hepatic failure without coma | ||
| K72.01 - Acute and subacute hepatic failure with coma | ||
| K72.1 - Chronic hepatic failure | ||
| K72.10 - Chronic hepatic failure without coma | ||
| K72.11 - Chronic hepatic failure with coma | ||
| K72.9 - Hepatic failure, unspecified | ||
| K72.90 - Hepatic failure, unspecified without coma | ||
| K72.91 - Hepatic failure, unspecified with coma | ||
| K74.0 - Hepatic fibrosis | ||
| K74.00 - Hepatic fibrosis, unspecified | ||
| K74.01 - Hepatic fibrosis, early fibrosis | ||
| K74.02 - Hepatic fibrosis, advanced fibrosis | ||
| K74.1 - Hepatic sclerosis | ||
| K74.2 - Hepatic fibrosis with hepatic sclerosis | ||
| K74.3 - Primary biliary cirrhosis | ||
| K74.4 - Secondary biliary cirrhosis | ||
| K74.5 - Biliary cirrhosis, unspecified | ||
| K74.6 - Other and unspecified cirrhosis of liver | ||
| K74.60 - Unspecified cirrhosis of liver | ||
| K74.69 - Other cirrhosis of liver | ||
| K75.0 - Abscess of liver | ||
| K75.1 - Phlebitis of portal vein | ||
| K75.2 - Nonspecific reactive hepatitis | ||
| K75.3 - Granulomatous hepatitis, not elsewhere classified | ||
| K75.4 - Autoimmune hepatitis | ||
| K75.8 - Other specified inflammatory liver diseases | ||
| K75.81 - Nonalcoholic steatohepatitis (NASH) | ||
| K75.89 - Other specified inflammatory liver diseases | ||
| K75.9 - Inflammatory liver disease, unspecified | ||
| K76.0 - Fatty (change of) liver, not elsewhere classified | ||
| K76.1 - Chronic passive congestion of liver | ||
| K76.2 - Central hemorrhagic necrosis of liver | ||
| K76.3 - Infarction of liver | ||
| K76.4 - Peliosis hepatis | ||
| K76.5 - Hepatic veno-occlusive disease | ||
| K76.6 - Portal hypertension | ||
| K76.7 - Hepatorenal syndrome | ||
| K76.8 - Other specified diseases of liver | ||
| K76.81 - Hepatopulmonary syndrome | ||
| K76.89 - Other specified diseases of liver | ||
| K76.9 - Liver disease, unspecified | ||
| K80.0 - Calculus of gallbladder with acute cholecystitis | ||
| K80.00 - Calculus of gallbladder with acute cholecystitis without obstruction | ||
| K80.01 - Calculus of gallbladder with acute cholecystitis with obstruction | ||
| K80.1 - Calculus of gallbladder with other cholecystitis | ||
| K80.10 - Calculus of gallbladder with chronic cholecystitis without obstruction | ||
| K80.11 - Calculus of gallbladder with chronic cholecystitis with obstruction | ||
| K80.12 - Calculus of gallbladder with acute and chronic cholecystitis without obstruction | ||
| K80.13 - Calculus of gallbladder with acute and chronic cholecystitis with obstruction | ||
| K80.18 - Calculus of gallbladder with other cholecystitis without obstruction | ||
| K80.19 - Calculus of gallbladder with other cholecystitis with obstruction | ||
| K80.2 - Calculus of gallbladder without cholecystitis | ||
| K80.20 - Calculus of gallbladder without cholecystitis without obstruction | ||
| K80.21 - Calculus of gallbladder without cholecystitis with obstruction | ||
| K80.3 - Calculus of bile duct with cholangitis | ||
| K80.30 - Calculus of bile duct with cholangitis, unspecified, without obstruction | ||
| K80.31 - Calculus of bile duct with cholangitis, unspecified, with obstruction | ||
| K80.32 - Calculus of bile duct with acute cholangitis without obstruction | ||
| K80.33 - Calculus of bile duct with acute cholangitis with obstruction | ||
| K80.34 - Calculus of bile duct with chronic cholangitis without obstruction | ||
| K80.35 - Calculus of bile duct with chronic cholangitis with obstruction | ||
| K80.36 - Calculus of bile duct with acute and chronic cholangitis without obstruction | ||
| K80.37 - Calculus of bile duct with acute and chronic cholangitis with obstruction | ||
| K80.4 - Calculus of bile duct with cholecystitis | ||
| K80.40 - Calculus of bile duct with cholecystitis, unspecified, without obstruction | ||
| K80.41 - Calculus of bile duct with cholecystitis, unspecified, with obstruction | ||
| K80.42 - Calculus of bile duct with acute cholecystitis without obstruction | ||
| K80.43 - Calculus of bile duct with acute cholecystitis with obstruction | ||
| K80.44 - Calculus of bile duct with chronic cholecystitis without obstruction | ||
| K80.45 - Calculus of bile duct with chronic cholecystitis with obstruction | ||
| K80.46 - Calculus of bile duct with acute and chronic cholecystitis without obstruction | ||
| K80.47 - Calculus of bile duct with acute and chronic cholecystitis with obstruction | ||
| K80.5 - Calculus of bile duct without cholangitis or cholecystitis | ||
| K80.50 - Calculus of bile duct without cholangitis or cholecystitis without obstruction | ||
| K80.51 - Calculus of bile duct without cholangitis or cholecystitis with obstruction | ||
| K80.6 - Calculus of gallbladder and bile duct with cholecystitis | ||
| K80.60 - Calculus of gallbladder and bile duct with cholecystitis, unspecified, without obstruction | ||
| K80.61 - Calculus of gallbladder and bile duct with cholecystitis, unspecified, with obstruction | ||
| K80.62 - Calculus of gallbladder and bile duct with acute cholecystitis without obstruction | ||
| K80.63 - Calculus of gallbladder and bile duct with acute cholecystitis with obstruction | ||
| K80.64 - Calculus of gallbladder and bile duct with chronic cholecystitis without obstruction | ||
| K80.65 - Calculus of gallbladder and bile duct with chronic cholecystitis with obstruction | ||
| K80.66 - Calculus of gallbladder and bile duct with acute and chronic cholecystitis without obstruction | ||
| K80.67 - Calculus of gallbladder and bile duct with acute and chronic cholecystitis with obstruction | ||
| K80.7 - Calculus of gallbladder and bile duct without cholecystitis | ||
| K80.70 - Calculus of gallbladder and bile duct without cholecystitis without obstruction | ||
| K80.71 - Calculus of gallbladder and bile duct without cholecystitis with obstruction | ||
| K80.8 - Other cholelithiasis | ||
| K80.80 - Other cholelithiasis without obstruction | ||
| K80.81 - Other cholelithiasis with obstruction | ||
| K81.0 - Acute cholecystitis | ||
| K81.1 - Chronic cholecystitis | ||
| K81.2 - Acute cholecystitis with chronic cholecystitis | ||
| K81.9 - Cholecystitis, unspecified | ||
| K82.A1 - Gangrene of gallbladder in cholecystitis | ||
| K82.A2 - Perforation of gallbladder in cholecystitis | ||
| K83.0 - Cholangitis | ||
| K83.01 - Primary sclerosing cholangitis | ||
| K83.09 - Other cholangitis | ||
| K83.1 - Obstruction of bile duct | ||
| K83.2 - Perforation of bile duct | ||
| K83.3 - Fistula of bile duct | ||
| K83.4 - Spasm of sphincter of Oddi | ||
| K83.5 - Biliary cyst | ||
| K83.8 - Other specified diseases of biliary tract | ||
| K83.9 - Disease of biliary tract, unspecified | ||
| K85.0 - Idiopathic acute pancreatitis | ||
| K85.00 - Idiopathic acute pancreatitis without necrosis or infection | ||
| K85.01 - Idiopathic acute pancreatitis with uninfected necrosis | ||
| K85.02 - Idiopathic acute pancreatitis with infected necrosis | ||
| K85.1 - Biliary acute pancreatitis | ||
| K85.10 - Biliary acute pancreatitis without necrosis or infection | ||
| K85.11 - Biliary acute pancreatitis with uninfected necrosis | ||
| K85.12 - Biliary acute pancreatitis with infected necrosis | ||
| K85.2 - Alcohol induced acute pancreatitis | ||
| K85.20 - Alcohol induced acute pancreatitis without necrosis or infection | ||
| K85.21 - Alcohol induced acute pancreatitis with uninfected necrosis | ||
| K85.22 - Alcohol induced acute pancreatitis with infected necrosis | ||
| K85.3 - Drug induced acute pancreatitis | ||
| K85.30 - Drug induced acute pancreatitis without necrosis or infection | ||
| K85.31 - Drug induced acute pancreatitis with uninfected necrosis | ||
| K85.32 - Drug induced acute pancreatitis with infected necrosis | ||
| K85.8 - Other acute pancreatitis | ||
| K85.80 - Other acute pancreatitis without necrosis or infection | ||
| K85.81 - Other acute pancreatitis with uninfected necrosis | ||
| K85.82 - Other acute pancreatitis with infected necrosis | ||
| K85.9 - Acute pancreatitis, unspecified | ||
| K85.90 - Acute pancreatitis without necrosis or infection, unspecified | ||
| K85.91 - Acute pancreatitis with uninfected necrosis, unspecified | ||
| K85.92 - Acute pancreatitis with infected necrosis, unspecified | ||
| K86.0 - Alcohol-induced chronic pancreatitis | ||
| K86.1 - Other chronic pancreatitis | ||
| K86.2 - Cyst of pancreas | ||
| K86.3 - Pseudocyst of pancreas | ||
| K86.8 - Other specified diseases of pancreas | ||
| K86.81 - Exocrine pancreatic insufficiency | ||
| K86.89 - Other specified diseases of pancreas | ||
| K86.9 - Disease of pancreas, unspecified | ||
| K90.0 - Celiac disease | ||
| K90.1 - Tropical sprue | ||
| K90.2 - Blind loop syndrome, not elsewhere classified | ||
| K90.3 - Pancreatic steatorrhea | ||
| K90.4 - Other malabsorption due to intolerance | ||
| K90.41 - Non-celiac gluten sensitivity | ||
| K90.49 - Malabsorption due to intolerance, not elsewhere classified | ||
| K90.8 - Other intestinal malabsorption | ||
| K90.81 - Whipple's disease | ||
| K90.89 - Other intestinal malabsorption | ||
| K90.9 - Intestinal malabsorption, unspecified | ||
| M36.0 - Dermato(poly)myositis in neoplastic disease | ||
| M36.1 - Arthropathy in neoplastic disease | ||
| M36.2 - Hemophilic arthropathy | ||
| M36.3 - Arthropathy in other blood disorders | ||
| M36.4 - Arthropathy in hypersensitivity reactions classified elsewhere | ||
| M36.8 - Systemic disorders of connective tissue in other diseases classified elsewhere | ||
| O98.4 - Viral hepatitis complicating pregnancy, childbirth and the puerperium | ||
| O98.41 - Viral hepatitis complicating pregnancy | ||
| O98.411 - Viral hepatitis complicating pregnancy, first trimester | ||
| O98.412 - Viral hepatitis complicating pregnancy, second trimester | ||
| O98.413 - Viral hepatitis complicating pregnancy, third trimester | ||
| O98.419 - Viral hepatitis complicating pregnancy, unspecified trimester | ||
| O98.42 - Viral hepatitis complicating childbirth | ||
| O98.43 - Viral hepatitis complicating the puerperium | ||
| P04.11 - Newborn affected by maternal antineoplastic chemotherapy | ||
| P58.0 - Neonatal jaundice due to bruising | ||
| P58.1 - Neonatal jaundice due to bleeding | ||
| P58.2 - Neonatal jaundice due to infection | ||
| P58.3 - Neonatal jaundice due to polycythemia | ||
| P58.4 - Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn | ||
| P58.41 - Neonatal jaundice due to drugs or toxins transmitted from mother | ||
| P58.42 - Neonatal jaundice due to drugs or toxins given to newborn | ||
| P58.5 - Neonatal jaundice due to swallowed maternal blood | ||
| P58.8 - Neonatal jaundice due to other specified excessive hemolysis | ||
| P58.9 - Neonatal jaundice due to excessive hemolysis, unspecified | ||
| P59.0 - Neonatal jaundice associated with preterm delivery | ||
| P59.1 - Inspissated bile syndrome | ||
| P59.2 - Neonatal jaundice from other and unspecified hepatocellular damage | ||
| P59.20 - Neonatal jaundice from unspecified hepatocellular damage | ||
| P59.29 - Neonatal jaundice from other hepatocellular damage | ||
| P59.3 - Neonatal jaundice from breast milk inhibitor | ||
| P59.8 - Neonatal jaundice from other specified causes | ||
| P59.9 - Neonatal jaundice, unspecified | ||
| P91.819 - Neonatal encephalopathy, unspecified | ||
| Q82.0 - Hereditary lymphedema | ||
| Q82.1 - Xeroderma pigmentosum | ||
| Q82.2 - Congenital cutaneous mastocytosis | ||
| Q82.3 - Incontinentia pigmenti | ||
| Q82.4 - Ectodermal dysplasia (anhidrotic) | ||
| Q82.5 - Congenital non-neoplastic nevus | ||
| Q82.6 - Congenital sacral dimple | ||
| Q82.8 - Other specified congenital malformations of skin | ||
| Q82.9 - Congenital malformation of skin, unspecified | ||
| R10.0 - Acute abdomen | ||
| R10.1 - Pain localized to upper abdomen | ||
| R10.10 - Upper abdominal pain, unspecified | ||
| R10.11 - Right upper quadrant pain | ||
| R10.12 - Left upper quadrant pain | ||
| R10.13 - Epigastric pain | ||
| R10.2 - Pelvic and perineal pain | ||
| R10.3 - Pain localized to other parts of lower abdomen | ||
| R10.30 - Lower abdominal pain, unspecified | ||
| R10.31 - Right lower quadrant pain | ||
| R10.32 - Left lower quadrant pain | ||
| R10.33 - Periumbilical pain | ||
| R10.8 - Other abdominal pain | ||
| R10.81 - Abdominal tenderness | ||
| R10.811 - Right upper quadrant abdominal tenderness | ||
| R10.812 - Left upper quadrant abdominal tenderness | ||
| R10.813 - Right lower quadrant abdominal tenderness | ||
| R10.814 - Left lower quadrant abdominal tenderness | ||
| R10.815 - Periumbilic abdominal tenderness | ||
| R10.816 - Epigastric abdominal tenderness | ||
| R10.817 - Generalized abdominal tenderness | ||
| R10.819 - Abdominal tenderness, unspecified site | ||
| R10.82 - Rebound abdominal tenderness | ||
| R10.821 - Right upper quadrant rebound abdominal tenderness | ||
| R10.822 - Left upper quadrant rebound abdominal tenderness | ||
| R10.823 - Right lower quadrant rebound abdominal tenderness | ||
| R10.824 - Left lower quadrant rebound abdominal tenderness | ||
| R10.825 - Periumbilic rebound abdominal tenderness | ||
| R10.826 - Epigastric rebound abdominal tenderness | ||
| R10.827 - Generalized rebound abdominal tenderness | ||
| R10.829 - Rebound abdominal tenderness, unspecified site | ||
| R10.83 - Colic | ||
| R10.84 - Generalized abdominal pain | ||
| R10.9 - Unspecified abdominal pain | ||
| R18.0 - Malignant ascites | ||
| R18.8 - Other ascites | ||
| R19.0 - Intra-abdominal and pelvic swelling, mass and lump | ||
| R19.00 - Intra-abdominal and pelvic swelling, mass and lump, unspecified site | ||
| R19.01 - Right upper quadrant abdominal swelling, mass and lump | ||
| R19.02 - Left upper quadrant abdominal swelling, mass and lump | ||
| R19.03 - Right lower quadrant abdominal swelling, mass and lump | ||
| R19.04 - Left lower quadrant abdominal swelling, mass and lump | ||
| R19.05 - Periumbilic swelling, mass or lump | ||
| R19.06 - Epigastric swelling, mass or lump | ||
| R19.07 - Generalized intra-abdominal and pelvic swelling, mass and lump | ||
| R19.09 - Other intra-abdominal and pelvic swelling, mass and lump | ||
| R19.1 - Abnormal bowel sounds | ||
| R19.11 - Absent bowel sounds | ||
| R19.12 - Hyperactive bowel sounds | ||
| R19.15 - Other abnormal bowel sounds | ||
| R19.2 - Visible peristalsis | ||
| R19.3 - Abdominal rigidity | ||
| R19.30 - Abdominal rigidity, unspecified site | ||
| R19.31 - Right upper quadrant abdominal rigidity | ||
| R19.32 - Left upper quadrant abdominal rigidity | ||
| R19.33 - Right lower quadrant abdominal rigidity | ||
| R19.34 - Left lower quadrant abdominal rigidity | ||
| R19.35 - Periumbilic abdominal rigidity | ||
| R19.36 - Epigastric abdominal rigidity | ||
| R19.37 - Generalized abdominal rigidity | ||
| R19.4 - Change in bowel habit | ||
| R19.5 - Other fecal abnormalities | ||
| R19.6 - Halitosis | ||
| R19.7 - Diarrhea, unspecified | ||
| R19.8 - Other specified symptoms and signs involving the digestive system and abdomen | ||
| R50.2 - Drug induced fever | ||
| R50.8 - Other specified fever | ||
| R50.81 - Fever presenting with conditions classified elsewhere | ||
| R50.82 - Postprocedural fever | ||
| R50.83 - Postvaccination fever | ||
| R50.84 - Febrile nonhemolytic transfusion reaction | ||
| R50.9 - Fever, unspecified | ||
| R65.1 - Systemic inflammatory response syndrome (SIRS) of non-infectious origin | ||
| R65.10 - Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction | ||
| R65.11 - Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunction | ||
| R65.2 - Severe sepsis | ||
| R65.20 - Severe sepsis without septic shock | ||
| R65.21 - Severe sepsis with septic shock | ||
| R74.0 - Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH] | ||
| R74.01 - Elevation of levels of liver transaminase levels | ||
| R74.02 - Elevation of levels of lactic acid dehydrogenase [LDH] | ||
| R74.8 - Abnormal levels of other serum enzymes | ||
| R74.9 - Abnormal serum enzyme level, unspecified | ||
| R85.0 - Abnormal level of enzymes in specimens from digestive organs and abdominal cavity | ||
| R85.1 - Abnormal level of hormones in specimens from digestive organs and abdominal cavity | ||
| R85.2 - Abnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity | ||
| R85.3 - Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity | ||
| R85.4 - Abnormal immunological findings in specimens from digestive organs and abdominal cavity | ||
| R85.5 - Abnormal microbiological findings in specimens from digestive organs and abdominal cavity | ||
| R85.6 - Abnormal cytological findings in specimens from digestive organs and abdominal cavity | ||
| R85.61 - Abnormal cytologic smear of anus | ||
| R85.610 - Atypical squamous cells of undetermined significance on cytologic smear of anus (ASC-US) | ||
| R85.611 - Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of anus (ASC-H) | ||
| R85.612 - Low grade squamous intraepithelial lesion on cytologic smear of anus (LGSIL) | ||
| R85.613 - High grade squamous intraepithelial lesion on cytologic smear of anus (HGSIL) | ||
| R85.614 - Cytologic evidence of malignancy on smear of anus | ||
| R85.615 - Unsatisfactory cytologic smear of anus | ||
| R85.616 - Satisfactory anal smear but lacking transformation zone | ||
| R85.618 - Other abnormal cytological findings on specimens from anus | ||
| R85.619 - Unspecified abnormal cytological findings in specimens from anus | ||
| R85.69 - Abnormal cytological findings in specimens from other digestive organs and abdominal cavity | ||
| R85.7 - Abnormal histological findings in specimens from digestive organs and abdominal cavity | ||
| R85.8 - Other abnormal findings in specimens from digestive organs and abdominal cavity | ||
| R85.81 - Anal high risk human papillomavirus (HPV) DNA test positive | ||
| R85.82 - Anal low risk human papillomavirus (HPV) DNA test positive | ||
| R85.89 - Other abnormal findings in specimens from digestive organs and abdominal cavity | ||
| R85.9 - Unspecified abnormal finding in specimens from digestive organs and abdominal cavity | ||
| R94.0 - Abnormal results of function studies of central nervous system | ||
| R94.01 - Abnormal electroencephalogram [EEG] | ||
| R94.02 - Abnormal brain scan | ||
| R94.09 - Abnormal results of other function studies of central nervous system | ||
| R94.1 - Abnormal results of function studies of peripheral nervous system and special senses | ||
| R94.11 - Abnormal results of function studies of eye | ||
| R94.110 - Abnormal electro-oculogram [EOG] | ||
| R94.111 - Abnormal electroretinogram [ERG] | ||
| R94.112 - Abnormal visually evoked potential [VEP] | ||
| R94.113 - Abnormal oculomotor study | ||
| R94.118 - Abnormal results of other function studies of eye | ||
| R94.12 - Abnormal results of function studies of ear and other special senses | ||
| R94.120 - Abnormal auditory function study | ||
| R94.121 - Abnormal vestibular function study | ||
| R94.128 - Abnormal results of other function studies of ear and other special senses | ||
| R94.13 - Abnormal results of function studies of peripheral nervous system | ||
| R94.130 - Abnormal response to nerve stimulation, unspecified | ||
| R94.131 - Abnormal electromyogram [EMG] | ||
| R94.138 - Abnormal results of other function studies of peripheral nervous system | ||
| R94.2 - Abnormal results of pulmonary function studies | ||
| R94.3 - Abnormal results of cardiovascular function studies | ||
| R94.30 - Abnormal result of cardiovascular function study, unspecified | ||
| R94.31 - Abnormal electrocardiogram [ECG] [EKG] | ||
| R94.39 - Abnormal result of other cardiovascular function study | ||
| R94.4 - Abnormal results of kidney function studies | ||
| R94.5 - Abnormal results of liver function studies | ||
| R94.6 - Abnormal results of thyroid function studies | ||
| R94.7 - Abnormal results of other endocrine function studies | ||
| R94.8 - Abnormal results of function studies of other organs and systems | ||
| T39.0 - Poisoning by, adverse effect of and underdosing of salicylates | ||
| T39.01 - Poisoning by, adverse effect of and underdosing of aspirin | ||
| T39.011 - Poisoning by aspirin, accidental (unintentional) | ||
| T39.011A - Poisoning by aspirin, accidental (unintentional), initial encounter | ||
| T39.011D - Poisoning by aspirin, accidental (unintentional), subsequent encounter | ||
| T39.011S - Poisoning by aspirin, accidental (unintentional), sequela | ||
| T39.012 - Poisoning by aspirin, intentional self-harm | ||
| T39.012A - Poisoning by aspirin, intentional self-harm, initial encounter | ||
| T39.012D - Poisoning by aspirin, intentional self-harm, subsequent encounter | ||
| T39.012S - Poisoning by aspirin, intentional self-harm, sequela | ||
| T39.013 - Poisoning by aspirin, assault | ||
| T39.013A - Poisoning by aspirin, assault, initial encounter | ||
| T39.013D - Poisoning by aspirin, assault, subsequent encounter | ||
| T39.013S - Poisoning by aspirin, assault, sequela | ||
| T39.014 - Poisoning by aspirin, undetermined | ||
| T39.014A - Poisoning by aspirin, undetermined, initial encounter | ||
| T39.014D - Poisoning by aspirin, undetermined, subsequent encounter | ||
| T39.014S - Poisoning by aspirin, undetermined, sequela | ||
| T39.015 - Adverse effect of aspirin | ||
| T39.015A - Adverse effect of aspirin, initial encounter | ||
| T39.015D - Adverse effect of aspirin, subsequent encounter | ||
| T39.015S - Adverse effect of aspirin, sequela | ||
| T39.016 - Underdosing of aspirin | ||
| T39.016A - Underdosing of aspirin, initial encounter | ||
| T39.016D - Underdosing of aspirin, subsequent encounter | ||
| T39.016S - Underdosing of aspirin, sequela | ||
| T39.09 - Poisoning by, adverse effect of and underdosing of other salicylates | ||
| T39.091 - Poisoning by salicylates, accidental (unintentional) | ||
| T39.091A - Poisoning by salicylates, accidental (unintentional), initial encounter | ||
| T39.091D - Poisoning by salicylates, accidental (unintentional), subsequent encounter | ||
| T39.091S - Poisoning by salicylates, accidental (unintentional), sequela | ||
| T39.092 - Poisoning by salicylates, intentional self-harm | ||
| T39.092A - Poisoning by salicylates, intentional self-harm, initial encounter | ||
| T39.092D - Poisoning by salicylates, intentional self-harm, subsequent encounter | ||
| T39.092S - Poisoning by salicylates, intentional self-harm, sequela | ||
| T39.093 - Poisoning by salicylates, assault | ||
| T39.093A - Poisoning by salicylates, assault, initial encounter | ||
| T39.093D - Poisoning by salicylates, assault, subsequent encounter | ||
| T39.093S - Poisoning by salicylates, assault, sequela | ||
| T39.094 - Poisoning by salicylates, undetermined | ||
| T39.094A - Poisoning by salicylates, undetermined, initial encounter | ||
| T39.094D - Poisoning by salicylates, undetermined, subsequent encounter | ||
| T39.094S - Poisoning by salicylates, undetermined, sequela | ||
| T39.095 - Adverse effect of salicylates | ||
| T39.095A - Adverse effect of salicylates, initial encounter | ||
| T39.095D - Adverse effect of salicylates, subsequent encounter | ||
| T39.095S - Adverse effect of salicylates, sequela | ||
| T39.096 - Underdosing of salicylates | ||
| T39.096A - Underdosing of salicylates, initial encounter | ||
| T39.096D - Underdosing of salicylates, subsequent encounter | ||
| T39.096S - Underdosing of salicylates, sequela | ||
| T39.1 - Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives | ||
| T39.1X - Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives | ||
| T39.1X1 - Poisoning by 4-Aminophenol derivatives, accidental (unintentional) | ||
| T39.1X1A - Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter | ||
| T39.1X1D - Poisoning by 4-Aminophenol derivatives, accidental (unintentional), subsequent encounter | ||
| T39.1X1S - Poisoning by 4-Aminophenol derivatives, accidental (unintentional), sequela | ||
| T39.1X2 - Poisoning by 4-Aminophenol derivatives, intentional self-harm | ||
| T39.1X2A - Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter | ||
| T39.1X2D - Poisoning by 4-Aminophenol derivatives, intentional self-harm, subsequent encounter | ||
| T39.1X2S - Poisoning by 4-Aminophenol derivatives, intentional self-harm, sequela | ||
| T39.1X3 - Poisoning by 4-Aminophenol derivatives, assault | ||
| T39.1X3A - Poisoning by 4-Aminophenol derivatives, assault, initial encounter | ||
| T39.1X3D - Poisoning by 4-Aminophenol derivatives, assault, subsequent encounter | ||
| T39.1X3S - Poisoning by 4-Aminophenol derivatives, assault, sequela | ||
| T39.1X4 - Poisoning by 4-Aminophenol derivatives, undetermined | ||
| T39.1X4A - Poisoning by 4-Aminophenol derivatives, undetermined, initial encounter | ||
| T39.1X4D - Poisoning by 4-Aminophenol derivatives, undetermined, subsequent encounter | ||
| T39.1X4S - Poisoning by 4-Aminophenol derivatives, undetermined, sequela | ||
| T39.1X5 - Adverse effect of 4-Aminophenol derivatives | ||
| T39.1X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | ||
| T39.1X5D - Adverse effect of 4-Aminophenol derivatives, subsequent encounter | ||
| T39.1X5S - Adverse effect of 4-Aminophenol derivatives, sequela | ||
| T39.1X6 - Underdosing of 4-Aminophenol derivatives | ||
| T39.1X6A - Underdosing of 4-Aminophenol derivatives, initial encounter | ||
| T39.1X6D - Underdosing of 4-Aminophenol derivatives, subsequent encounter | ||
| T39.1X6S - Underdosing of 4-Aminophenol derivatives, sequela | ||
| T39.2 - Poisoning by, adverse effect of and underdosing of pyrazolone derivatives | ||
| T39.2X - Poisoning by, adverse effect of and underdosing of pyrazolone derivatives | ||
| T39.2X1 - Poisoning by pyrazolone derivatives, accidental (unintentional) | ||
| T39.2X1A - Poisoning by pyrazolone derivatives, accidental (unintentional), initial encounter | ||
| T39.2X1D - Poisoning by pyrazolone derivatives, accidental (unintentional), subsequent encounter | ||
| T39.2X1S - Poisoning by pyrazolone derivatives, accidental (unintentional), sequela | ||
| T39.2X2 - Poisoning by pyrazolone derivatives, intentional self-harm | ||
| T39.2X2A - Poisoning by pyrazolone derivatives, intentional self-harm, initial encounter | ||
| T39.2X2D - Poisoning by pyrazolone derivatives, intentional self-harm, subsequent encounter | ||
| T39.2X2S - Poisoning by pyrazolone derivatives, intentional self-harm, sequela | ||
| T39.2X3 - Poisoning by pyrazolone derivatives, assault | ||
| T39.2X3A - Poisoning by pyrazolone derivatives, assault, initial encounter | ||
| T39.2X3D - Poisoning by pyrazolone derivatives, assault, subsequent encounter | ||
| T39.2X3S - Poisoning by pyrazolone derivatives, assault, sequela | ||
| T39.2X4 - Poisoning by pyrazolone derivatives, undetermined | ||
| T39.2X4A - Poisoning by pyrazolone derivatives, undetermined, initial encounter | ||
| T39.2X4D - Poisoning by pyrazolone derivatives, undetermined, subsequent encounter | ||
| T39.2X4S - Poisoning by pyrazolone derivatives, undetermined, sequela | ||
| T39.2X5 - Adverse effect of pyrazolone derivatives | ||
| T39.2X5A - Adverse effect of pyrazolone derivatives, initial encounter | ||
| T39.2X5D - Adverse effect of pyrazolone derivatives, subsequent encounter | ||
| T39.2X5S - Adverse effect of pyrazolone derivatives, sequela | ||
| T39.2X6 - Underdosing of pyrazolone derivatives | ||
| T39.2X6A - Underdosing of pyrazolone derivatives, initial encounter | ||
| T39.2X6D - Underdosing of pyrazolone derivatives, subsequent encounter | ||
| T39.2X6S - Underdosing of pyrazolone derivatives, sequela | ||
| T39.3 - Poisoning by, adverse effect of and underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] | ||
| T39.31 - Poisoning by, adverse effect of and underdosing of propionic acid derivatives | ||
| T39.311 - Poisoning by propionic acid derivatives, accidental (unintentional) | ||
| T39.311A - Poisoning by propionic acid derivatives, accidental (unintentional), initial encounter | ||
| T39.311D - Poisoning by propionic acid derivatives, accidental (unintentional), subsequent encounter | ||
| T39.311S - Poisoning by propionic acid derivatives, accidental (unintentional), sequela | ||
| T39.312 - Poisoning by propionic acid derivatives, intentional self-harm | ||
| T39.312A - Poisoning by propionic acid derivatives, intentional self-harm, initial encounter | ||
| T39.312D - Poisoning by propionic acid derivatives, intentional self-harm, subsequent encounter | ||
| T39.312S - Poisoning by propionic acid derivatives, intentional self-harm, sequela | ||
| T39.313 - Poisoning by propionic acid derivatives, assault | ||
| T39.313A - Poisoning by propionic acid derivatives, assault, initial encounter | ||
| T39.313D - Poisoning by propionic acid derivatives, assault, subsequent encounter | ||
| T39.313S - Poisoning by propionic acid derivatives, assault, sequela | ||
| T39.314 - Poisoning by propionic acid derivatives, undetermined | ||
| T39.314A - Poisoning by propionic acid derivatives, undetermined, initial encounter | ||
| T39.314D - Poisoning by propionic acid derivatives, undetermined, subsequent encounter | ||
| T39.314S - Poisoning by propionic acid derivatives, undetermined, sequela | ||
| T39.315 - Adverse effect of propionic acid derivatives | ||
| T39.315A - Adverse effect of propionic acid derivatives, initial encounter | ||
| T39.315D - Adverse effect of propionic acid derivatives, subsequent encounter | ||
| T39.315S - Adverse effect of propionic acid derivatives, sequela | ||
| T39.316 - Underdosing of propionic acid derivatives | ||
| T39.316A - Underdosing of propionic acid derivatives, initial encounter | ||
| T39.316D - Underdosing of propionic acid derivatives, subsequent encounter | ||
| T39.316S - Underdosing of propionic acid derivatives, sequela | ||
| T39.39 - Poisoning by, adverse effect of and underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] | ||
| T39.391 - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional) | ||
| T39.391A - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), initial encounter | ||
| T39.391D - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), subsequent encounter | ||
| T39.391S - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), sequela | ||
| T39.392 - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm | ||
| T39.392A - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter | ||
| T39.392D - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, subsequent encounter | ||
| T39.392S - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, sequela | ||
| T39.393 - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault | ||
| T39.393A - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, initial encounter | ||
| T39.393D - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, subsequent encounter | ||
| T39.393S - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, sequela | ||
| T39.394 - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined | ||
| T39.394A - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, initial encounter | ||
| T39.394D - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, subsequent encounter | ||
| T39.394S - Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, sequela | ||
| T39.395 - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID] | ||
| T39.395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | ||
| T39.395D - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter | ||
| T39.395S - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela | ||
| T39.396 - Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] | ||
| T39.396A - Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | ||
| T39.396D - Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter | ||
| T39.396S - Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela | ||
| T39.4 - Poisoning by, adverse effect of and underdosing of antirheumatics, not elsewhere classified | ||
| T39.4X - Poisoning by, adverse effect of and underdosing of antirheumatics, not elsewhere classified | ||
| T39.4X1 - Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional) | ||
| T39.4X1A - Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), initial encounter | ||
| T39.4X1D - Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), subsequent encounter | ||
| T39.4X1S - Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), sequela | ||
| T39.4X2 - Poisoning by antirheumatics, not elsewhere classified, intentional self-harm | ||
| T39.4X2A - Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, initial encounter | ||
| T39.4X2D - Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, subsequent encounter | ||
| T39.4X2S - Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, sequela | ||
| T39.4X3 - Poisoning by antirheumatics, not elsewhere classified, assault | ||
| T39.4X3A - Poisoning by antirheumatics, not elsewhere classified, assault, initial encounter | ||
| T39.4X3D - Poisoning by antirheumatics, not elsewhere classified, assault, subsequent encounter | ||
| T39.4X3S - Poisoning by antirheumatics, not elsewhere classified, assault, sequela | ||
| T39.4X4 - Poisoning by antirheumatics, not elsewhere classified, undetermined | ||
| T39.4X4A - Poisoning by antirheumatics, not elsewhere classified, undetermined, initial encounter | ||
| T39.4X4D - Poisoning by antirheumatics, not elsewhere classified, undetermined, subsequent encounter | ||
| T39.4X4S - Poisoning by antirheumatics, not elsewhere classified, undetermined, sequela | ||
| T39.4X5 - Adverse effect of antirheumatics, not elsewhere classified | ||
| T39.4X5A - Adverse effect of antirheumatics, not elsewhere classified, initial encounter | ||
| T39.4X5D - Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter | ||
| T39.4X5S - Adverse effect of antirheumatics, not elsewhere classified, sequela | ||
| T39.4X6 - Underdosing of antirheumatics, not elsewhere classified | ||
| T39.4X6A - Underdosing of antirheumatics, not elsewhere classified, initial encounter | ||
| T39.4X6D - Underdosing of antirheumatics, not elsewhere classified, subsequent encounter | ||
| T39.4X6S - Underdosing of antirheumatics, not elsewhere classified, sequela | ||
| T39.8 - Poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified | ||
| T39.8X - Poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified | ||
| T39.8X1 - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional) | ||
| T39.8X1A - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), initial encounter | ||
| T39.8X1D - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), subsequent encounter | ||
| T39.8X1S - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), sequela | ||
| T39.8X2 - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm | ||
| T39.8X2A - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, initial encounter | ||
| T39.8X2D - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, subsequent encounter | ||
| T39.8X2S - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, sequela | ||
| T39.8X3 - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault | ||
| T39.8X3A - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, initial encounter | ||
| T39.8X3D - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, subsequent encounter | ||
| T39.8X3S - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, sequela | ||
| T39.8X4 - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined | ||
| T39.8X4A - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, initial encounter | ||
| T39.8X4D - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, subsequent encounter | ||
| T39.8X4S - Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, sequela | ||
| T39.8X5 - Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified | ||
| T39.8X5A - Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter | ||
| T39.8X5D - Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter | ||
| T39.8X5S - Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela | ||
| T39.8X6 - Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified | ||
| T39.8X6A - Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter | ||
| T39.8X6D - Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter | ||
| T39.8X6S - Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela | ||
| T39.9 - Poisoning by, adverse effect of and underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic | ||
| T39.91 - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional) | ||
| T39.91XA - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), initial encounter | ||
| T39.91XD - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), subsequent encounter | ||
| T39.91XS - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), sequela | ||
| T39.92 - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm | ||
| T39.92XA - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, initial encounter | ||
| T39.92XD - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, subsequent encounter | ||
| T39.92XS - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, sequela | ||
| T39.93 - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault | ||
| T39.93XA - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, initial encounter | ||
| T39.93XD - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, subsequent encounter | ||
| T39.93XS - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, sequela | ||
| T39.94 - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined | ||
| T39.94XA - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, initial encounter | ||
| T39.94XD - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, subsequent encounter | ||
| T39.94XS - Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, sequela | ||
| T39.95 - Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic | ||
| T39.95XA - Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter | ||
| T39.95XD - Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter | ||
| T39.95XS - Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela | ||
| T39.96 - Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic | ||
| T39.96XA - Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter | ||
| T39.96XD - Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter | ||
| T39.96XS - Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela | ||
| T80.810 - Extravasation of vesicant antineoplastic chemotherapy | ||
| T80.810A - Extravasation of vesicant antineoplastic chemotherapy, initial encounter | ||
| T80.810D - Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter | ||
| T80.810S - Extravasation of vesicant antineoplastic chemotherapy, sequela | ||
| T86.42 - Liver transplant failure | ||
| Z14.1 - Cystic fibrosis carrier | ||
| Z22.322 - Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus | ||
| Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy | ||
| Z51.11 - Encounter for antineoplastic chemotherapy | ||
| Z79.5 - Long term (current) use of steroids | ||
| Z79.8 - Other long term (current) drug therapy | ||
| Z79.89 - Other long term (current) drug therapy | ||
| Z79.891 - Long term (current) use of opiate analgesic | ||
| Z79.899 - Other long term (current) drug therapy | ||
| Z85.0 - Personal history of malignant neoplasm of digestive organs | ||
| Z85.00 - Personal history of malignant neoplasm of unspecified digestive organ | ||
| Z85.01 - Personal history of malignant neoplasm of esophagus | ||
| Z85.02 - Personal history of malignant neoplasm of stomach | ||
| Z85.020 - Personal history of malignant carcinoid tumor of stomach | ||
| Z85.028 - Personal history of other malignant neoplasm of stomach | ||
| Z85.03 - Personal history of malignant neoplasm of large intestine | ||
| Z85.030 - Personal history of malignant carcinoid tumor of large intestine | ||
| Z85.038 - Personal history of other malignant neoplasm of large intestine | ||
| Z85.04 - Personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus | ||
| Z85.040 - Personal history of malignant carcinoid tumor of rectum | ||
| Z85.048 - Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus | ||
| Z85.05 - Personal history of malignant neoplasm of liver | ||
| Z85.06 - Personal history of malignant neoplasm of small intestine | ||
| Z85.060 - Personal history of malignant carcinoid tumor of small intestine | ||
| Z85.068 - Personal history of other malignant neoplasm of small intestine | ||
| Z85.07 - Personal history of malignant neoplasm of pancreas | ||
| Z85.09 - Personal history of malignant neoplasm of other digestive organs | ||
| Z85.1 - Personal history of malignant neoplasm of trachea, bronchus and lung | ||
| Z85.11 - Personal history of malignant neoplasm of bronchus and lung | ||
| Z85.110 - Personal history of malignant carcinoid tumor of bronchus and lung | ||
| Z85.118 - Personal history of other malignant neoplasm of bronchus and lung | ||
| Z85.12 - Personal history of malignant neoplasm of trachea | ||
| Z85.2 - Personal history of malignant neoplasm of other respiratory and intrathoracic organs | ||
| Z85.20 - Personal history of malignant neoplasm of unspecified respiratory organ | ||
| Z85.21 - Personal history of malignant neoplasm of larynx | ||
| Z85.22 - Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses | ||
| Z85.23 - Personal history of malignant neoplasm of thymus | ||
| Z85.230 - Personal history of malignant carcinoid tumor of thymus | ||
| Z85.238 - Personal history of other malignant neoplasm of thymus | ||
| Z85.29 - Personal history of malignant neoplasm of other respiratory and intrathoracic organs | ||
| Z85.3 - Personal history of malignant neoplasm of breast | ||
| Z85.4 - Personal history of malignant neoplasm of genital organs | ||
| Z85.40 - Personal history of malignant neoplasm of unspecified female genital organ | ||
| Z85.41 - Personal history of malignant neoplasm of cervix uteri | ||
| Z85.42 - Personal history of malignant neoplasm of other parts of uterus | ||
| Z85.43 - Personal history of malignant neoplasm of ovary | ||
| Z85.44 - Personal history of malignant neoplasm of other female genital organs | ||
| Z85.45 - Personal history of malignant neoplasm of unspecified male genital organ | ||
| Z85.46 - Personal history of malignant neoplasm of prostate | ||
| Z85.47 - Personal history of malignant neoplasm of testis | ||
| Z85.48 - Personal history of malignant neoplasm of epididymis | ||
| Z85.49 - Personal history of malignant neoplasm of other male genital organs | ||
| Z85.5 - Personal history of malignant neoplasm of urinary tract | ||
| Z85.50 - Personal history of malignant neoplasm of unspecified urinary tract organ | ||
| Z85.51 - Personal history of malignant neoplasm of bladder | ||
| Z85.52 - Personal history of malignant neoplasm of kidney | ||
| Z85.520 - Personal history of malignant carcinoid tumor of kidney | ||
| Z85.528 - Personal history of other malignant neoplasm of kidney | ||
| Z85.53 - Personal history of malignant neoplasm of renal pelvis | ||
| Z85.54 - Personal history of malignant neoplasm of ureter | ||
| Z85.59 - Personal history of malignant neoplasm of other urinary tract organ | ||
| Z85.6 - Personal history of leukemia | ||
| Z85.7 - Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues | ||
| Z85.71 - Personal history of Hodgkin lymphoma | ||
| Z85.72 - Personal history of non-Hodgkin lymphomas | ||
| Z85.79 - Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues | ||
| Z85.8 - Personal history of malignant neoplasms of other organs and systems | ||
| Z85.81 - Personal history of malignant neoplasm of lip, oral cavity, and pharynx | ||
| Z85.810 - Personal history of malignant neoplasm of tongue | ||
| Z85.818 - Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx | ||
| Z85.819 - Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx | ||
| Z85.82 - Personal history of malignant neoplasm of skin | ||
| Z85.820 - Personal history of malignant melanoma of skin | ||
| Z85.821 - Personal history of Merkel cell carcinoma | ||
| Z85.828 - Personal history of other malignant neoplasm of skin | ||
| Z85.83 - Personal history of malignant neoplasm of bone and soft tissue | ||
| Z85.830 - Personal history of malignant neoplasm of bone | ||
| Z85.831 - Personal history of malignant neoplasm of soft tissue | ||
| Z85.84 - Personal history of malignant neoplasm of eye and nervous tissue | ||
| Z85.840 - Personal history of malignant neoplasm of eye | ||
| Z85.841 - Personal history of malignant neoplasm of brain | ||
| Z85.848 - Personal history of malignant neoplasm of other parts of nervous tissue | ||
| Z85.85 - Personal history of malignant neoplasm of endocrine glands | ||
| Z85.850 - Personal history of malignant neoplasm of thyroid | ||
| Z85.858 - Personal history of malignant neoplasm of other endocrine glands | ||
| Z85.89 - Personal history of malignant neoplasm of other organs and systems | ||
| Z85.9 - Personal history of malignant neoplasm, unspecified | ||
| Z86.003 - Personal history of in-situ neoplasm of oral cavity, esophagus and stomach | ||
| Z86.14 - Personal history of Methicillin resistant Staphylococcus aureus infection | ||
| Z92.21 - Personal history of antineoplastic chemotherapy | ||